Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP742313.RAMhxvRbUmE4N6xJjP7CoJTylA_EDjCM1hJrHr_MDl6Qg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP742313.RAMhxvRbUmE4N6xJjP7CoJTylA_EDjCM1hJrHr_MDl6Qg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP742313.RAMhxvRbUmE4N6xJjP7CoJTylA_EDjCM1hJrHr_MDl6Qg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP742313.RAMhxvRbUmE4N6xJjP7CoJTylA_EDjCM1hJrHr_MDl6Qg130_provenance.
- NP742313.RAMhxvRbUmE4N6xJjP7CoJTylA_EDjCM1hJrHr_MDl6Qg130_assertion description "[Our identification of XRCC2 as a breast cancer susceptibility gene thus increases the proportion of breast cancers that are associated with homologous recombination-DNA-repair dysfunction and Fanconi anemia and could therefore benefit from specific targeted treatments such as PARP (poly ADP ribose polymerase) inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP742313.RAMhxvRbUmE4N6xJjP7CoJTylA_EDjCM1hJrHr_MDl6Qg130_provenance.
- NP742313.RAMhxvRbUmE4N6xJjP7CoJTylA_EDjCM1hJrHr_MDl6Qg130_assertion evidence source_evidence_literature NP742313.RAMhxvRbUmE4N6xJjP7CoJTylA_EDjCM1hJrHr_MDl6Qg130_provenance.
- NP742313.RAMhxvRbUmE4N6xJjP7CoJTylA_EDjCM1hJrHr_MDl6Qg130_assertion SIO_000772 22464251 NP742313.RAMhxvRbUmE4N6xJjP7CoJTylA_EDjCM1hJrHr_MDl6Qg130_provenance.
- NP742313.RAMhxvRbUmE4N6xJjP7CoJTylA_EDjCM1hJrHr_MDl6Qg130_assertion wasDerivedFrom befree-20140225 NP742313.RAMhxvRbUmE4N6xJjP7CoJTylA_EDjCM1hJrHr_MDl6Qg130_provenance.
- NP742313.RAMhxvRbUmE4N6xJjP7CoJTylA_EDjCM1hJrHr_MDl6Qg130_assertion wasGeneratedBy ECO_0000203 NP742313.RAMhxvRbUmE4N6xJjP7CoJTylA_EDjCM1hJrHr_MDl6Qg130_provenance.
- befree-20140225 importedOn "2014-02-25" NP742313.RAMhxvRbUmE4N6xJjP7CoJTylA_EDjCM1hJrHr_MDl6Qg130_provenance.